Fiera Capital Corp lessened its position in shares of ChampionX Co. (NASDAQ:CHX - Free Report) by 2.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,228,415 shares of the company's stock after selling 30,440 shares during the quarter. Fiera Capital Corp owned about 0.64% of ChampionX worth $33,401,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Creative Planning boosted its holdings in shares of ChampionX by 2.1% in the 3rd quarter. Creative Planning now owns 146,507 shares of the company's stock worth $4,417,000 after purchasing an additional 3,025 shares during the period. Blue Trust Inc. boosted its holdings in ChampionX by 442.4% during the 3rd quarter. Blue Trust Inc. now owns 1,329 shares of the company's stock valued at $44,000 after acquiring an additional 1,084 shares during the period. Raymond James & Associates boosted its holdings in ChampionX by 3.1% during the 3rd quarter. Raymond James & Associates now owns 225,285 shares of the company's stock valued at $6,792,000 after acquiring an additional 6,695 shares during the period. Copeland Capital Management LLC boosted its holdings in ChampionX by 0.6% during the 3rd quarter. Copeland Capital Management LLC now owns 883,066 shares of the company's stock valued at $26,624,000 after acquiring an additional 5,080 shares during the period. Finally, Narwhal Capital Management boosted its holdings in ChampionX by 17.9% during the 3rd quarter. Narwhal Capital Management now owns 197,138 shares of the company's stock valued at $5,944,000 after acquiring an additional 29,966 shares during the period. Hedge funds and other institutional investors own 98.99% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Citigroup dropped their price objective on ChampionX from $45.00 to $40.00 and set a "buy" rating for the company in a report on Thursday, November 14th.
View Our Latest Report on ChampionX
ChampionX Stock Down 1.0 %
NASDAQ CHX traded down $0.30 on Monday, reaching $29.44. 2,609,778 shares of the stock traded hands, compared to its average volume of 3,181,253. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.20 and a current ratio of 1.99. The company has a fifty day moving average price of $28.43 and a 200-day moving average price of $29.76. The company has a market cap of $5.62 billion, a price-to-earnings ratio of 17.84 and a beta of 2.35. ChampionX Co. has a 12 month low of $25.57 and a 12 month high of $39.95.
ChampionX (NASDAQ:CHX - Get Free Report) last issued its earnings results on Tuesday, February 4th. The company reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.47 by $0.03. ChampionX had a return on equity of 19.84% and a net margin of 8.81%. As a group, research analysts forecast that ChampionX Co. will post 1.92 EPS for the current fiscal year.
ChampionX Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, January 3rd were given a $0.095 dividend. This represents a $0.38 annualized dividend and a dividend yield of 1.29%. The ex-dividend date of this dividend was Friday, January 3rd. ChampionX's payout ratio is 23.03%.
ChampionX Profile
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
Recommended Stories

Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.